Etiology and outcome of tibiotalocalcaneal and tibiotalar arthrodesis in a 10-year evaluation

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00031612

Enrollment

500

Registered

2025-03-05

Start date

2022-08-01

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M19.17

Interventions

Group 1: Tibiotalocalcaneal and tibiotalar arthrodesis and their outcome, in end-stage posttraumatic osteoarthritis of the ankle, are evaluated. Clinical outcome using validated scores (Olerud & Molan

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: All patients with posttraumatic osteoarthritis of the ankle who underwent arthrodesis of the tibiotalocalcaneal or tibiotalar joint.

Exclusion criteria

Exclusion criteria: Minimum age less than 18 years, ability to consent not given, patients with tumor-related surgery.

Design outcomes

Primary

Measure	Time frame
Clinical outcome using validated scores (Olerud & Molander, SF-12, FFI-D), follow-up period 6.5 years on average.	—

Secondary

Measure	Time frame
Amputation, death, lost to follow-up lost	—

Countries

Germany

Contacts

Public ContactSebastian Fischer

BG Unfallklinik Frankfurt am Main

Sebastian.Fischer@BGU-Frankfurt.de+49(0)69475-0

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026